{"id":"https://openalex.org/W2766655935","doi":"https://doi.org/10.1111/dom.13133","title":"Treatment satisfaction with ITCA 650, a novel drug\u2010device delivering continuous exenatide, versus twice\u2010daily injections of exenatide in type 2 diabetics using metformin","display_name":"Treatment satisfaction with ITCA 650, a novel drug\u2010device delivering continuous exenatide, versus twice\u2010daily injections of exenatide in type 2 diabetics using metformin","publication_year":2017,"publication_date":"2017-10-20","ids":{"openalex":"https://openalex.org/W2766655935","doi":"https://doi.org/10.1111/dom.13133","mag":"2766655935","pmid":"https://pubmed.ncbi.nlm.nih.gov/29053202"},"language":"en","primary_location":{"id":"doi:10.1111/dom.13133","doi":"https://doi.org/10.1111/dom.13133","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.13133","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045462483","display_name":"Robert R. Henry","orcid":"https://orcid.org/0000-0002-4821-0117","observed_orcids":["https://orcid.org/0000-0002-4821-0117"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Henry","raw_affiliation_strings":["Division of Endocrinology and Metabolism, Department of Medicine, University of California at San Diego, La Jolla, California"],"raw_orcid":"https://orcid.org/0000-0002-4821-0117","affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Metabolism, Department of Medicine, University of California at San Diego, La Jolla, California","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[{"id":"https://openalex.org/I4210112007","display_name":"Dallas Diabetes Research Center","ror":"https://ror.org/022jeg055","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210112007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio Rosenstock","raw_affiliation_strings":["Dallas Diabetes Research Center at Medical City, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas Diabetes Research Center at Medical City, Dallas, Texas","institution_ids":["https://openalex.org/I4210112007"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John F. McCarthy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094353","display_name":"Intarcia Therapeutics (United States)","ror":"https://ror.org/00s0pgz81","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094353"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John F. McCarthy","raw_affiliation_strings":["Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California","institution_ids":["https://openalex.org/I4210094353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029624539","display_name":"Ginger Smith Carls","orcid":"https://orcid.org/0000-0003-2724-2731","observed_orcids":["https://orcid.org/0000-0003-2724-2731"]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ginger Carls","raw_affiliation_strings":["Analysis Group, Menlo Park, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Menlo Park, California","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001199980","display_name":"Tom Alessi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094353","display_name":"Intarcia Therapeutics (United States)","ror":"https://ror.org/00s0pgz81","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094353"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Alessi","raw_affiliation_strings":["Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California","institution_ids":["https://openalex.org/I4210094353"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Yee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094353","display_name":"Intarcia Therapeutics (United States)","ror":"https://ror.org/00s0pgz81","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094353"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Yee","raw_affiliation_strings":["Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California","institution_ids":["https://openalex.org/I4210094353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032895459","display_name":"Michelle A. Baron","orcid":"https://orcid.org/0000-0001-7530-5069","observed_orcids":["https://orcid.org/0000-0001-7530-5069"]},"institutions":[{"id":"https://openalex.org/I4210094353","display_name":"Intarcia Therapeutics (United States)","ror":"https://ror.org/00s0pgz81","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094353"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michelle Baron","raw_affiliation_strings":["Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intarcia Therapeutics, Inc., Boston, Massachusetts and Hayward, Hayward, California","institution_ids":["https://openalex.org/I4210094353"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5032895459"],"corresponding_institution_ids":["https://openalex.org/I4210094353"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":0.5929,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.7023035,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"20","issue":"3","first_page":"638","last_page":"645"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.03150000050663948,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.8859999775886536},{"id":"https://openalex.org/keywords/osmotic-minipump","display_name":"osmotic minipump","score":0.8899999856948853},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8519999980926514},{"id":"https://openalex.org/keywords/treatment-satisfaction","display_name":"treatment satisfaction","score":0.8029999732971191},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8769999742507935},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.5419999957084656},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8230000138282776},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6140000224113464},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7070000171661377},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9319103956222534},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8004573583602905},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7776526212692261},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.7176392078399658},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5739568471908569},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5419796705245972},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5215063691139221},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.44538795948028564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44454994797706604},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4073198437690735},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2517869472503662},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.21291494369506836},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.17025107145309448}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004867","descriptor_name":"Equipment Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000295","qualifier_name":"instrumentation","is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.13133","doi":"https://doi.org/10.1111/dom.13133","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.13133","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:29053202","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29053202","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320314793","display_name":"Intarcia Therapeutics","ror":"https://ror.org/00s0pgz81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1735988280","https://openalex.org/W1984740259","https://openalex.org/W1990917635","https://openalex.org/W1992891539","https://openalex.org/W1997485108","https://openalex.org/W2009830637","https://openalex.org/W2017222422","https://openalex.org/W2035790817","https://openalex.org/W2043900831","https://openalex.org/W2047076943","https://openalex.org/W2047187313","https://openalex.org/W2054568668","https://openalex.org/W2055754603","https://openalex.org/W2056824040","https://openalex.org/W2062883844","https://openalex.org/W2065319712","https://openalex.org/W2077725161","https://openalex.org/W2093738306","https://openalex.org/W2099171812","https://openalex.org/W2099352903","https://openalex.org/W2099968605","https://openalex.org/W2106758571","https://openalex.org/W2109238714","https://openalex.org/W2112256994","https://openalex.org/W2114117378","https://openalex.org/W2115977452","https://openalex.org/W2123269659","https://openalex.org/W2123850120","https://openalex.org/W2124234371","https://openalex.org/W2136821381","https://openalex.org/W2139020169","https://openalex.org/W2147007805","https://openalex.org/W2147325147","https://openalex.org/W2156160269","https://openalex.org/W2160088494","https://openalex.org/W2162934281","https://openalex.org/W2164416879","https://openalex.org/W2167596589","https://openalex.org/W2493860075","https://openalex.org/W2586129535","https://openalex.org/W2588441560","https://openalex.org/W2743088090","https://openalex.org/W2745170751","https://openalex.org/W4241059420","https://openalex.org/W4250230810"],"related_works":["https://openalex.org/W2123269659","https://openalex.org/W2330717441","https://openalex.org/W2097644966","https://openalex.org/W2054568668","https://openalex.org/W2774301756","https://openalex.org/W2065319712","https://openalex.org/W7100034471","https://openalex.org/W1494439095","https://openalex.org/W1498870695","https://openalex.org/W2050201308"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"evaluate":[2],"treatment":[3,135,175,188,220,251],"satisfaction":[4,136,176,189,221],"in":[5,23,133,161],"patients":[6,180,230],"with":[7,114,199,231],"type":[8],"2":[9,58],"diabetes":[10],"(T2D)":[11],"not":[12],"adequately":[13],"controlled":[14],"by":[15,137],"metformin,":[16],"randomized":[17,72,117],"to":[18,73,99,118,185,195,213,227,238],"ITCA":[19,76,80,94,123,128,172,186,200,216,224,239],"650":[20,77,81,95,129,173,225,240],"(continuous":[21],"exenatide":[22,28],"osmotic":[24],"mini-pump)":[25],"vs":[26,140],"twice-daily":[27],"injections":[29],"(Ex-BID).":[30],"MATERIALS":[31],"AND":[32],"METHODS:":[33],"The":[34],"Diabetes":[35],"Medication":[36],"Satisfaction":[37],"Tool":[38],"(DM-SAT)":[39],"was":[40,177],"administered":[41],"and":[42,50,84,151,163,174,191,233,247],"assessments":[43],"were":[44,71,97,116,165,183],"made":[45],"at":[46],"baseline,":[47],"Week":[48,51,138],"8":[49,139],"20":[52,78],"during":[53],"a":[54,109],"24-week":[55],"open-label":[56],"phase":[57],"trial.":[59],"In":[60,89],"Stage":[61,90,104,157],"I":[62,105],"(Weeks":[63,92],"1-12),":[64],"155":[65],"patients,":[66],"comprising":[67],"the":[68,103,211],"ITT":[69],"population,":[70],"3":[74],"groups:":[75],"\u03bcg/day,":[79],"40":[82,119],"\u03bcg/day":[83,122],"Ex-BID":[85,115,143,182],"10":[86],"\u03bcg":[87],"BID.":[88],"II":[91],"13-24),":[93],"groups":[96],"re-randomized":[98],"either":[100],"remain":[101],"on":[102],"dose":[106,169],"or":[107,120],"receive":[108],"higher":[110],"dose.":[111],"Patients":[112,126],"treated":[113,198],"60":[121],"650.":[124,201],"RESULTS:":[125],"using":[127,142,181],"reported":[130],"significant":[131],"increases":[132],"overall":[134,152,250],"those":[141,196,235],"(P":[144],"<":[145],".01),":[146],"despite":[147],"similar":[148,194],"clinical":[149],"efficacy":[150],"rates":[153],"of":[154,171,206],"nausea.":[155],"During":[156],"II,":[158],"further":[159],"improvement":[160],"HbA1c":[162],"weight":[164],"seen":[166],"after":[167],"3-fold":[168],"escalation":[170],"maintained.":[178],"When":[179],"switched":[184,237],"650,":[187,217],"increased":[190,249],"reached":[192],"levels":[193],"initially":[197],"Neither":[202],"GI":[203],"side":[204],"effects":[205],"nausea":[207],"and/or":[208],"vomiting,":[209],"nor":[210],"procedure":[212],"sub-dermally":[214],"place":[215],"significantly":[218,248],"impacted":[219],"scores.":[222],"CONCLUSION:":[223],"added":[226],"metformin":[228],"for":[229,234],"T2D,":[232],"who":[236],"from":[241],"Ex-BID,":[242],"meaningfully":[243],"improved":[244],"glucose":[245],"control":[246],"satisfaction.":[252]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-11-10T00:00:00"}